# EDGAR Filing Document

**Accession Number:** 0000799295
**File Stem:** 0001752724-25-202204
**Filing Date:** 2025-8
**Character Count:** 53538
**Document Hash:** db3d4483026fabddd90cf1d5fcdd5c88
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001752724-25-202204.hdr.sgml**: 20250825

**ACCESSION NUMBER**: 0001752724-25-202204

**CONFORMED SUBMISSION TYPE**: NPORT-P

**PUBLIC DOCUMENT COUNT**: 2

**CONFORMED PERIOD OF REPORT**: 20250630

**FILED AS OF DATE**: 20250825

**DATE AS OF CHANGE**: 20250825

**PERIOD START**: 20250930

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** BNY Mellon Investment Funds I
- **CENTRAL INDEX KEY:** 0000799295

**ORGANIZATION NAME:**
- **EIN:** 043106135
- **STATE OF INCORPORATION:** MA
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** NPORT-P
- **SEC ACT:** 1940 Act
- **SEC FILE NUMBER:** 811-04813
- **FILM NUMBER:** 251250276

**BUSINESS ADDRESS:**
- **STREET 1:** C/O BNY MELLON INVESTMENT ADVISER, INC.
- **STREET 2:** 240 GREENWICH STREET
- **CITY:** NEW YORK
- **STATE:** NY
- **ZIP:** 10286
- **BUSINESS PHONE:** 212-922-6400

**MAIL ADDRESS:**
- **STREET 1:** C/O BNY MELLON INVESTMENT ADVISER, INC.
- **STREET 2:** 240 GREENWICH STREET
- **CITY:** NEW YORK
- **STATE:** NY
- **ZIP:** 10286

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** DREYFUS INVESTMENT FUNDS
- **DATE OF NAME CHANGE:** 20081201

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** MELLON INSTITUTIONAL FUNDS INVESTMENT TRUST
- **DATE OF NAME CHANGE:** 20030707

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** STANDISH AYER & WOOD INVESTMENT TRUST
- **DATE OF NAME CHANGE:** 19920703

## Series and Classes Contracts Data

### BNY Mellon Small/Mid Cap Growth Fund (Series ID: S000011499)

| Class ID   | Class Name   | Ticker Symbol   |
|:---|:---|:---|
| C000031760 | Class I      | SDSCX           |
| C000075527 | Class A      | DBMAX           |
| C000075528 | Class C      | DBMCX           |
| C000130460 | Class Y      | DBMYX           |
| C000193013 | Class Z      | DBMZX           |

## Nport-Ex

BNY Mellon Small/Mid Cap Growth Fund

STATEMENT OF INVESTMENTS

June 30, 2025 (Unaudited)

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <br>

------

---

| | | |
|:---|:---|:---|
| Description | Shares | Value ($) |
| **Common Stocks — 96.6%** | **Common Stocks — 96.6%** | **Common Stocks — 96.6%** |
| **Automobiles & Components — 1.8%** | **Automobiles & Components — 1.8%** | **Automobiles & Components — 1.8%** |
| Modine Manufacturing Co. <sup>(a),(b)</sup> <br>| 200419 | **19741271** |
| **Banks — 1.8%** | **Banks — 1.8%** | **Banks — 1.8%** |
| SouthState Corp. | 210067 | **19332466** |
| **Capital Goods — 30.8%** | **Capital Goods — 30.8%** | **Capital Goods — 30.8%** |
| AeroVironment, Inc. <sup>(a),(b)</sup> <br>| 87304 | 24877275 |
| Axon Enterprise, Inc. <sup>(a)</sup> <br>| 31860 | 26378168 |
| Builders FirstSource, Inc. <sup>(a)</sup> <br>| 87474 | 10207341 |
| Construction Partners, Inc., Cl. A <sup>(a)</sup> <br>| 158257 | 16819554 |
| Curtiss-Wright Corp. | 88099 | 43040766 |
| Esab Corp. | 148933 | 17953873 |
| Hubbell, Inc. | 50560 | 20649209 |
| Karman Holdings, Inc. <sup>(a),(b)</sup> <br>| 732656 | 36903883 |
| MYR Group, Inc. <sup>(a)</sup> <br>| 114491 | 20774392 |
| QXO, Inc. <sup>(a),(b)</sup> <br>| 744800 | 16042992 |
| SiteOne Landscape Supply, Inc. <sup>(a)</sup> <br>| 113905 | 13775671 |
| The Timken Company | 280776 | 20370299 |
| Vertiv Holdings Co., Cl. A | 160821 | 20651025 |
| WESCO International, Inc. | 120052 | 22233630 |
| Woodward, Inc. | 84274 | 20654715 |
|  |  | **331332793** |
| **Commercial & Professional Services — 1.3%** | **Commercial & Professional Services — 1.3%** | **Commercial & Professional Services — 1.3%** |
| Casella Waste Systems, Inc., Cl. A <sup>(a)</sup> <br>| 125174 | **14442576** |
| **Consumer Discretionary Distribution & Retail — 7.7%** | **Consumer Discretionary Distribution & Retail — 7.7%** | **Consumer Discretionary Distribution & Retail — 7.7%** |
| Chewy, Inc., Cl. A <sup>(a)</sup> <br>| 446224 | 19018067 |
| Ollie's Bargain Outlet Holdings, Inc. <sup>(a)</sup> <br>| 177479 | 23388183 |
| Pool Corp. <sup>(b)</sup> <br>| 51594 | 15038619 |
| Warby Parker, Inc., Cl. A <sup>(a)</sup> <br>| 1157401 | 25381804 |
|  |  | **82826673** |
| **Consumer Services — 4.6%** | **Consumer Services — 4.6%** | **Consumer Services — 4.6%** |
| Cava Group, Inc. <sup>(a),(b)</sup> <br>| 143338 | 12073360 |
| Dutch Bros, Inc., Cl. A <sup>(a)</sup> <br>| 215053 | 14703173 |
| Planet Fitness, Inc., Cl. A <sup>(a)</sup> <br>| 206235 | 22489927 |
|  |  | **49266460** |
| **Consumer Staples Distribution & Retail — 4.7%** | **Consumer Staples Distribution & Retail — 4.7%** | **Consumer Staples Distribution & Retail — 4.7%** |
| BJ's Wholesale Club Holdings, Inc. <sup>(a)</sup> <br>| 174789 | 18847498 |
| Casey's General Stores, Inc. | 60907 | 31079015 |
|  |  | **49926513** |
| **Financial Services — .7%** | **Financial Services — .7%** | **Financial Services — .7%** |
| Tradeweb Markets, Inc., Cl. A | 51742 | **7575029** |
| **Food, Beverage & Tobacco — 1.4%** | **Food, Beverage & Tobacco — 1.4%** | **Food, Beverage & Tobacco — 1.4%** |
| Freshpet, Inc. <sup>(a),(b)</sup> <br>| 220341 | **14974374** |
| **Health Care Equipment & Services — 4.8%** | **Health Care Equipment & Services — 4.8%** | **Health Care Equipment & Services — 4.8%** |
| Guardant Health, Inc. <sup>(a)</sup> <br>| 243429 | 12668045 |
| Inspire Medical Systems, Inc. <sup>(a)</sup> <br>| 59235 | 7686926 |
| iRhythm Technologies, Inc. <sup>(a),(b)</sup> <br>| 126038 | 19404811 |
| Privia Health Group, Inc. <sup>(a)</sup> <br>| 510320 | 11737360 |
|  |  | **51497142** |

---

**3**

------

*STATEMENT OF INVESTMENTS (Unaudited) (continued)*

------

---

| | | |
|:---|:---|:---|
| Description | Shares | Value ($) |
| **Common Stocks — 96.6% (continued)** | **Common Stocks — 96.6% (continued)** | **Common Stocks — 96.6% (continued)** |
| **Insurance — 2.6%** | **Insurance — 2.6%** | **Insurance — 2.6%** |
| Assurant, Inc. | 95598 | 18879649 |
| The Baldwin Insurance Group, Inc. <sup>(a),(b)</sup> <br>| 217248 | 9300387 |
|  |  | **28180036** |
| **Pharmaceuticals, Biotechnology & Life Sciences — 15.0%** | **Pharmaceuticals, Biotechnology & Life Sciences — 15.0%** | **Pharmaceuticals, Biotechnology & Life Sciences — 15.0%** |
| Apogee Therapeutics, Inc. <sup>(a)</sup> <br>| 53073 | 2304960 |
| Ascendis Pharma A/S, ADR <sup>(a)</sup> <br>| 59617 | 10289894 |
| Bio-Techne Corp. | 393123 | 20226178 |
| Denali Therapeutics, Inc. <sup>(a)</sup> <br>| 205712 | 2877911 |
| GRAIL, Inc. <sup>(a),(b)</sup> <br>| 119465 | 6142890 |
| Illumina, Inc. <sup>(a)</sup> <br>| 225770 | 21540716 |
| Insmed, Inc. <sup>(a)</sup> <br>| 123809 | 12460138 |
| Madrigal Pharmaceuticals, Inc. <sup>(a)</sup> <br>| 15765 | 4771120 |
| Mirum Pharmaceuticals, Inc. <sup>(a)</sup> <br>| 110494 | 5623040 |
| Natera, Inc. <sup>(a)</sup> <br>| 87679 | 14812490 |
| Newamsterdam Pharma Co. NV <sup>(a),(b)</sup> <br>| 179446 | 3249767 |
| Repligen Corp. <sup>(a)</sup> <br>| 189509 | 23571129 |
| Soleno Therapeutics, Inc. <sup>(a)</sup> <br>| 124701 | 10447450 |
| Twist Bioscience Corp. <sup>(a)</sup> <br>| 173265 | 6374419 |
| Ultragenyx Pharmaceutical, Inc. <sup>(a)</sup> <br>| 106157 | 3859869 |
| uniQure NV <sup>(a)</sup> <br>| 163050 | 2272917 |
| Verona Pharma PLC, ADR <sup>(a)</sup> <br>| 67951 | 6426806 |
| Xenon Pharmaceuticals, Inc. <sup>(a),(b)</sup> <br>| 129500 | 4053350 |
|  |  | **161305044** |
| **Real Estate Management & Development — 2.0%** | **Real Estate Management & Development — 2.0%** | **Real Estate Management & Development — 2.0%** |
| CoStar Group, Inc. <sup>(a)</sup> <br>| 260905 | **20976762** |
| **Semiconductors & Semiconductor Equipment — 4.8%** | **Semiconductors & Semiconductor Equipment — 4.8%** | **Semiconductors & Semiconductor Equipment — 4.8%** |
| FormFactor, Inc. <sup>(a)</sup> <br>| 781601 | 26894890 |
| Rambus, Inc. <sup>(a)</sup> <br>| 380877 | 24383746 |
|  |  | **51278636** |
| **Software & Services — 10.7%** | **Software & Services — 10.7%** | **Software & Services — 10.7%** |
| Bentley Systems, Inc., Cl. B | 307815 | 16612776 |
| Cellebrite DI Ltd. <sup>(a)</sup> <br>| 479045 | 7664720 |
| Confluent, Inc., Cl. A <sup>(a)</sup> <br>| 589505 | 14696360 |
| CyberArk Software Ltd. <sup>(a)</sup> <br>| 39541 | 16088442 |
| HubSpot, Inc. <sup>(a)</sup> <br>| 16107 | 8965639 |
| Klaviyo, Inc., Cl. A <sup>(a)</sup> <br>| 335349 | 11261019 |
| Life360, Inc. <sup>(a),(b)</sup> <br>| 293607 | 19157857 |
| Monday.com Ltd. <sup>(a)</sup> <br>| 65671 | 20652216 |
|  |  | **115099029** |
| **Transportation — 1.9%** | **Transportation — 1.9%** | **Transportation — 1.9%** |
| Knight-Swift Transportation Holdings, Inc. | 465940 | **20608526** |
| &nbsp;&nbsp;&nbsp; **Total Common Stocks** <br>(cost $787,030,441)<br>|  | **1038363330** |
| **Private Equity — 2.2%** | **Private Equity — 2.2%** | **Private Equity — 2.2%** |
| **Consumer Staples Distribution & Retail — .6%** | **Consumer Staples Distribution & Retail — .6%** | **Consumer Staples Distribution & Retail — .6%** |
| Supplying Demand, Inc., Ser. E <sup>(a),(c)</sup> <br>| 497558 | **6532936** |
| **Pharmaceuticals, Biotechnology & Life Sciences — .5%** | **Pharmaceuticals, Biotechnology & Life Sciences — .5%** | **Pharmaceuticals, Biotechnology & Life Sciences — .5%** |
| Aspen Neuroscience, Ser. B <sup>(a),(c)</sup> <br>| 1963167 | **5025707** |
| **Real Estate Management & Development — .2%** | **Real Estate Management & Development — .2%** | **Real Estate Management & Development — .2%** |
| Roofstock, Ser. E <sup>(a),(c)</sup> <br>| 346123 | **2055971** |

---

**4**

------

---

| | | |
|:---|:---|:---|
| Description | Shares | Value ($) |
| **Private Equity — 2.2% (continued)** | **Private Equity — 2.2% (continued)** | **Private Equity — 2.2% (continued)** |
| **Software & Services — .9%** | **Software & Services — .9%** | **Software & Services — .9%** |
| Fundbox, Ser. D <sup>(a),(c)</sup> <br>| 702664 | 5326193 |
| Locus Robotics, Ser. F <sup>(a),(c)</sup> <br>| 101086 | 4557968 |
|  |  | **9884161** |
| &nbsp;&nbsp;&nbsp; **Total Private Equity** <br>(cost $34,978,403)<br>|  | **23498775** |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

---

| | | |
|:---|:---|:---|
|  | Number of Rights |  |
| **Rights — .0%** | **Rights — .0%** | **Rights — .0%** |
| **Health Care Equipment & Services — .0%** | **Health Care Equipment & Services — .0%** | **Health Care Equipment & Services — .0%** |
| &nbsp;&nbsp;&nbsp; ABIOMED, Inc., expiring 12/31/2049<sup>(c)</sup> <br>(cost $0)<br>| 160644 | **186347** |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

---

| | | | |
|:---|:---|:---|:---|
|  | 1-Day <br>Yield (%)<br>| Shares |  |
| **Investment Companies — .1%** | **Investment Companies — .1%** | **Investment Companies — .1%** | **Investment Companies — .1%** |
| **Registered Investment Companies — .1%** | **Registered Investment Companies — .1%** | **Registered Investment Companies — .1%** | **Registered Investment Companies — .1%** |
| &nbsp;&nbsp;&nbsp; Dreyfus Institutional Preferred Government Plus Money Market Fund, Institutional <br> Shares<sup>(d)</sup> <br>(cost $563,010)<br>| 4.47 | 563010 | **563010** |
| **Investment of Cash Collateral for Securities Loaned — 5.4%** |  |  |  |
| **Registered Investment Companies — 5.4%** |  |  |  |
| &nbsp;&nbsp;&nbsp; Dreyfus Institutional Preferred Government Plus Money Market Fund, Institutional <br> Shares<sup>(d)</sup> <br>(cost $58,078,796)<br>| 4.47 | 58078796 | **58078796** |
| **Total Investments** (cost $880,650,650) | **Total Investments** (cost $880,650,650) | **104.3%** | **1120690258** |
| **Liabilities, Less Cash and Receivables** | **Liabilities, Less Cash and Receivables** | **(4.3%)** | **(46197790)** |
| **Net Assets**  | **Net Assets**  | **100.0%** | **1074492468** |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

*ADR—American Depositary Receipt*<br>

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

<sup>(a)</sup> *Non-income producing security.*

<sup>(b)</sup> *Security, or portion thereof, on loan. At June 30, 2025, the value of the fund's securities on loan was $146,524,480 and the value of the collateral was* *$147,933,788, consisting of cash collateral of $58,078,796 and U.S. Government & Agency securities valued at $89,854,992. In addition, the value of* *collateral may include pending sales that are also on loan.* 

<sup>(c)</sup> *The fund held Level 3 securities at June 30, 2025. These securities were valued at $23,685,122 or 2.2% of net assets.*

<sup>(d)</sup> *Investment in affiliated issuer. The investment objective of this investment company is publicly available and can be found within the investment company's* *prospectus.* 

*See notes to statement of investments.*

**5**

------

Statement of Investments

BNY Mellon Small/Mid Cap Growth Fund

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <br>June 30, 2025 (Unaudited)

The following is a summary of the inputs used as of June 30, 2025 in valuing the fund's investments:

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | **Level 1 -** <br>**Unadjusted** <br>**Quoted Prices**<br>| **Level 2- Other** <br>**Significant** <br>**Observable Inputs**<br>| **Level 3-** <br>**Significant** <br>**Unobservable** <br>**Inputs**<br>| **Total** |
| **Assets ($)** |  |  |  |  |
| Investments in Securities:<sup>†</sup> <br>|  |  |  |  |
| Equity Securities - Common Stocks | &nbsp;&nbsp; 1038363330 | &nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp; **1038363330** |
| Equity Securities - Private Equity | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp; — | &nbsp;&nbsp; 23498775 | &nbsp;&nbsp; **23498775** |
| Rights | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 186347 | &nbsp;&nbsp; **186347** |
| Investment Companies | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 58641806 | &nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp; **58641806** |
|  | &nbsp;&nbsp; **1097005136** | &nbsp;&nbsp; **—** | &nbsp;&nbsp; **23685122** | &nbsp;&nbsp; **1120690258** |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

<sup>†</sup> *See Statement of Investments for additional detailed categorizations, if any.*

**6**

------

The Financial Accounting Standards Board ("FASB") Accounting Standards Codification ("ASC") is the exclusive reference of authoritative U.S. generally accepted accounting principles ("GAAP") recognized by the FASB to be applied by nongovernmental entities. Rules and interpretive releases of the Securities and Exchange Commission ("SEC") under authority of federal laws are also sources of authoritative GAAP for SEC registrants. The fund is an investment company and applies the accounting and reporting guidance of the FASB ASC Topic 946 Financial Services-Investment Companies. The fund's financial statements are prepared in accordance with GAAP, which may require the use of management estimates and assumptions. Actual results could differ from those estimates.

The fair value of a financial instrument is the amount that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date (i.e., the exit price). GAAP establishes a fair value hierarchy that prioritizes the inputs of valuation techniques used to measure fair value. This hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements).

Additionally, GAAP provides guidance on determining whether the volume and activity in a market has decreased significantly and whether such a decrease in activity results in transactions that are not orderly. GAAP requires enhanced disclosures around valuation inputs and techniques used during annual and interim periods.

Various inputs are used in determining the value of the fund's investments relating to fair value measurements. These inputs are summarized in the three broad levels listed below:

**Level 1**—unadjusted quoted prices in active markets for identical investments.

**Level 2**—other significant observable inputs (including quoted prices for similar investments, interest rates, prepayment speeds, credit risk, etc.).

**Level 3**—significant unobservable inputs (including the fund's own assumptions in determining the fair value of investments).

The inputs or methodology used for valuing securities are not necessarily an indication of the risk associated with investing in those securities.

Changes in valuation techniques may result in transfers in or out of an assigned level within the disclosure hierarchy. Valuation techniques used to value the fund's investments are as follows:

The Trust's Board of Trustees (the "Board") has designated the Adviser as the fund's valuation designee to make all fair value determinations with respect to the fund's portfolio investments, subject to the Board's oversight and pursuant to Rule 2a-5 under the Act.

Investments in equity securities are valued at the last sales price on the securities exchange or national securities market on which such securities are primarily traded. Securities listed on the National Market System for which market quotations are available are valued at the official closing price or, if there is no official closing price that day, at the last sales price. For open short positions, asked prices are used for valuation purposes. Bid price is used when no asked price is available. Registered investment companies that are not traded on an exchange are valued at their net asset value. All of the preceding securities are generally categorized within Level 1 of the fair value hierarchy.

Securities not listed on an exchange or the national securities market, or securities for which there were no transactions, are valued at the average of the most recent bid and asked prices. These securities are generally categorized within Level 2 of the fair value hierarchy.

Fair valuing of securities may be determined with the assistance of a pricing service using calculations based on indices of domestic securities and other appropriate indicators, such as prices of relevant ADRs and futures. Utilizing these techniques may result in transfers between Level 1 and Level 2 of the fair value hierarchy.

When market quotations or official closing prices are not readily available, or are determined not to accurately reflect fair value, such as when the value of a security has been significantly affected by events after the close of the exchange or market on which the security is principally traded, but before the fund calculates its net asset value, the fund may value these investments at fair value as determined in accordance with the procedures approved by the Board. Certain factors may be considered when fair valuing investments such as: fundamental analytical data, the nature and duration of restrictions on disposition, an evaluation of the forces that influence the market in which the securities are purchased and sold, and public trading in similar securities of the issuer or comparable issuers. These securities are either categorized within Level 2 or 3 of the fair value hierarchy depending on the relevant inputs used.

For securities where observable inputs are limited, assumptions about market activity and risk are used and such securities are generally categorized within Level 3 of the fair value hierarchy.

**7**

------

Investment in private equity securities will be fair valued by the Board in accordance with valuation procedures approved by the Board. Those portfolio valuations will be based on unobservable inputs and certain assumptions about how market participants would price the instrument. The fund expects that inputs into the determination of fair value of those investments will require significant management judgment or estimation. Because valuations may fluctuate over short periods of time and may be based on estimates, fair value determinations may differ materially from the value received in an actual transaction. Additionally, valuations of private companies are inherently uncertain. The fund's net asset value could be adversely affected if the fund's determinations regarding the fair value of those investments were materially higher or lower than the values that it ultimately realized upon the disposal of such investments. These securities are categorized within Level 3 of the fair value hierarchy.

Pursuant to a securities lending agreement with BNY, the fund may lend securities to qualified institutions. It is the fund's policy that, at origination, all loans are secured by collateral of at least 102% of the value of U.S. securities loaned and 105% of the value of foreign securities loaned. Collateral equivalent to at least 100% of the market value of securities on loan is maintained at all times. Collateral is either in the form of cash, which can be invested in certain money market mutual funds managed by the Adviser, or U.S. Government and Agency securities. The securities on loan, if any, are also disclosed in the fund's Statement of Investments. The fund is entitled to receive all dividends, interest and distributions on securities loaned, in addition to income earned as a result of the lending transaction. Should a borrower fail to return the securities in a timely manner, BNY is required to replace the securities for the benefit of the fund or credit the fund with the market value of the unreturned securities and is subrogated to the fund's rights against the borrower and the collateral. Additionally, the contractual maturity of security lending transactions are on an overnight and continuous basis.

At June 30, 2025, accumulated net unrealized appreciation on investments was $240,039,608, consisting of $272,257,545 gross unrealized appreciation and $32,217,937 gross unrealized depreciation.

At June 30, 2025, the cost of investments for federal income tax purposes was substantially the same as the cost for financial reporting purposes (see the Statement of Investments).

Additional investment related disclosures are hereby incorporated by reference to the annual and semi-annual reports previously filed with the SEC on Form N-CSR.

**8**

------

## Form NPORT-P: Monthly Portfolio Investments Report

### NPORT-P: Part A: General Information

**Item A.1. Information about the Registrant.**

- **a. Name of Registrant:** BNY Mellon Investment Funds I

- **b. Investment Company Act file number:** 811-04813

- **c. CIK number of Registrant:** 0000799295

- **d. LEI of Registrant:** 5493000M3XIJVKIWWS65

- **e. Address and telephone number of Registrant.**

  - **Street Address 1:** 240 Greenwich Street

  - **City:** New York

  - **State:** NY

  - **Foreign country:** US

  - **Zip / Postal Code:** 10286

  - **Telephone number:** 212-922-6400

**Item A.2. Information about the Series.**

- **a. Name of Series:** BNY Mellon Small/Mid Cap Growth Fund

- **b. EDGAR series identifier (if any):** S000011499

- **c. LEI of Series:** 549300DP427BBILWFN87

**Item A.3. Reporting period.**

- **a. Date of fiscal year-end:** 2025-09-30

- **b. Date as of which information is reported:** 2025-06-30

**Item A.4. Final filing**

Does the Fund anticipate that this will be its final filing on Form N-PORT? **No**

### Fund Information

**Total Assets:** $1135537232.67

**Total Liabilities:** $59674365.15

**Net Assets:** $1075862867.52

**Monthly Return Information**

| Class               | Month 1 Return (%)   | Month 2 Return (%)   | Month 3 Return (%)   |
|:---|:---|:---|:---|
| Class ID C000130460 | 2.30%                | 6.33%                | 7.10%                |
| Class ID C000193013 | 2.30%                | 6.31%                | 7.10%                |
| Class ID C000075528 | 2.21%                | 6.19%                | 7.04%                |
| Class ID C000075527 | 2.27%                | 6.31%                | 7.05%                |
| Class ID C000031760 | 2.33%                | 6.31%                | 7.09%                |

**Monthly Gains & Losses**

| Period   | Net Realized Gain/Loss   | Net Unrealized Appreciation/Depreciation   |
|:---|:---|:---|
| Month 1  | $8306776.48              | $13362543.73                               |
| Month 2  | $29707055.73             | $31773953.01                               |
| Month 3  | $14879701.74             | $57173853.47                               |

### Schedule of Portfolio Investments

| Name                                                              | Title                                                             | Identifiers                                   | Payoff Profile   | Asset Category   | Issuer Category   | Country   |   Balance | Units   | Value (USD)   | % of Net Assets   | Maturity Date   | Coupon Type   | Annualized Rate (%)   | Restricted?   |   Fair Value Level | Lending Status   |
|:---|:---|:---|:---|:---|:---|:---|---:|:---|:---|:---|:---|:---|:---|:---|---:|:---|
| GRAIL Inc                                                         | GRAIL Inc                                                         | CUSIP: 384747101<br>LEI: 2549009XSNESW3VE8024 | Long             | EC               | CORP              | US        |    120543 | NS      | $6198321.06   | 0.58%             |  |  |  | No            |                  1 | On Loan: —       |
| Life360 Inc                                                       | Life360 Inc                                                       | CUSIP: 532206109<br>LEI: 254900VO9VDOQBQAHF07 | Long             | EC               | CORP              | US        |    296253 | NS      | $19330508.25  | 1.80%             |  |  |  | No            |                  1 | On Loan: —       |
| Freshpet Inc                                                      | Freshpet Inc                                                      | CUSIP: 358039105<br>LEI: 549300S4ZK8ZQ6HNPN59 | Long             | EC               | CORP              | US        |    222326 | NS      | $15109274.96  | 1.40%             |  |  |  | No            |                  1 | On Loan: —       |
| Soleno Therapeutics Inc                                           | Soleno Therapeutics Inc                                           | CUSIP: 834203309<br>LEI: 5493003LCY77N7FXK844 | Long             | EC               | CORP              | US        |    125826 | NS      | $10541702.28  | 0.98%             |  |  |  | No            |                  1 | On Loan: No      |
| Karman Holdings Inc                                               | Karman Holdings Inc                                               | CUSIP: 485924104<br>LEI: N/A                  | Long             | EC               | CORP              | US        |    739261 | NS      | $37236576.57  | 3.46%             |  |  |  | No            |                  1 | On Loan: —       |
| Denali Therapeutics Inc                                           | Denali Therapeutics Inc                                           | CUSIP: 24823R105<br>LEI: 549300ZTQ2HO18L3Q830 | Long             | EC               | CORP              | US        |    207567 | NS      | $2903862.33   | 0.27%             |  |  |  | No            |                  1 | On Loan: No      |
| Madrigal Pharmaceuticals Inc                                      | Madrigal Pharmaceuticals Inc                                      | CUSIP: 558868105<br>LEI: 549300CHIMT2EUSNJB60 | Long             | EC               | CORP              | US        |     15908 | NS      | $4814397.12   | 0.45%             |  |  |  | No            |                  1 | On Loan: No      |
| Inspire Medical Systems Inc                                       | Inspire Medical Systems Inc                                       | CUSIP: 457730109<br>LEI: 549300XQQCQ7HCJKTW25 | Long             | EC               | CORP              | US        |     59769 | NS      | $7756223.13   | 0.72%             |  |  |  | No            |                  1 | On Loan: No      |
| Insmed Inc                                                        | Insmed Inc                                                        | CUSIP: 457669307<br>LEI: 529900Q55QAG41CCAC11 | Long             | EC               | CORP              | US        |    124926 | NS      | $12572552.64  | 1.17%             |  |  |  | No            |                  1 | On Loan: No      |
| Tradeweb Markets Inc                                              | Tradeweb Markets Inc                                              | CUSIP: 892672106<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     52208 | NS      | $7643251.20   | 0.71%             |  |  |  | No            |                  1 | On Loan: No      |
| Casey's General Stores Inc                                        | Casey's General Stores Inc                                        | CUSIP: 147528103<br>LEI: 549300CAFWSI86V66Q65 | Long             | EC               | CORP              | US        |     61456 | NS      | $31359153.12  | 2.91%             |  |  |  | No            |                  1 | On Loan: No      |
| ASPEN NEUROSCI                                                    | ASPEN NEUROSCI                                                    | CUSIP: 000000000<br>LEI: N/A                  | Long             | EC               | CORP              | US        |   1963167 | NS      | $5025707.52   | 0.47%             |  |  |  | Yes           |                  3 | On Loan: No      |
| Mirum Pharmaceuticals Inc                                         | Mirum Pharmaceuticals Inc                                         | CUSIP: 604749101<br>LEI: 254900YZKR40F7F27K81 | Long             | EC               | CORP              | US        |    111490 | NS      | $5673726.10   | 0.53%             |  |  |  | No            |                  1 | On Loan: No      |
| Hubbell Inc                                                       | Hubbell Inc                                                       | CUSIP: 443510607<br>LEI: 54930088VDQ6840Y6597 | Long             | EC               | CORP              | US        |     51015 | NS      | $20835036.15  | 1.94%             |  |  |  | No            |                  1 | On Loan: No      |
| iRhythm Technologies Inc                                          | iRhythm Technologies Inc                                          | CUSIP: 450056106<br>LEI: 549300FJI72RJGDQS384 | Long             | EC               | CORP              | US        |    127174 | NS      | $19579709.04  | 1.82%             |  |  |  | No            |                  1 | On Loan: —       |
| Esab Corp                                                         | Esab Corp                                                         | CUSIP: 29605J106<br>LEI: 549300ZNV0SWBXEIWT04 | Long             | EC               | CORP              | US        |    150275 | NS      | $18115651.25  | 1.68%             |  |  |  | No            |                  1 | On Loan: No      |
| Supplying Demand Inc Com Stk                                      | Supplying Demand Inc Com Stk                                      | CUSIP: 000000000<br>LEI: N/A                  | Long             | EC               | CORP              | US        |    497558 | NS      | $6532936.54   | 0.61%             |  |  |  | Yes           |                  3 | On Loan: No      |
| DREYFUS INSTITUTIONAL PREFERRED GOVERNMENT PLUS MONEY MARKET FUND | DREYFUS INSTITUTIONAL PREFERRED GOVERNMENT PLUS MONEY MARKET FUND | CUSIP: 000000000<br>LEI: N/A                  | Long             | STIV             | RF                | US        |  58774722 | NS      | $58774722.11  | 5.46%             |  |  |  | No            |                  1 | On Loan: No      |
| Cava Group Inc                                                    | Cava Group Inc                                                    | CUSIP: 148929102<br>LEI: N/A                  | Long             | EC               | CORP              | US        |    147413 | NS      | $12416596.99  | 1.15%             |  |  |  | No            |                  1 | On Loan: —       |
| Verona Pharma PLC                                                 | Verona Pharma PLC                                                 | CUSIP: 925050106<br>LEI: 213800EVI6O6J3TIAL06 | Long             | EC               | CORP              | GB        |     68563 | NS      | $6484688.54   | 0.60%             |  |  |  | No            |                  1 | On Loan: No      |
| uniQure NV                                                        | uniQure NV                                                        | CUSIP: 000000000<br>LEI: 724500RPCTZLFYJZ3S98 | Long             | EC               | CORP              | NL        |    164519 | NS      | $2293394.86   | 0.21%             |  |  |  | No            |                  1 | On Loan: No      |
| Chewy Inc                                                         | Chewy Inc                                                         | CUSIP: 16679L109<br>LEI: 254900NPQSTG9I422879 | Long             | EC               | CORP              | US        |    450246 | NS      | $19189484.52  | 1.78%             |  |  |  | No            |                  1 | On Loan: No      |
| WESCO International Inc                                           | WESCO International Inc                                           | CUSIP: 95082P105<br>LEI: 529900TXOGREY3WNJ434 | Long             | EC               | CORP              | US        |    121133 | NS      | $22433831.60  | 2.09%             |  |  |  | No            |                  1 | On Loan: No      |
| Fundbox                                                           | Fundbox                                                           | CUSIP: 000000000<br>LEI: N/A                  | Long             | EC               | CORP              | US        |    702664 | NS      | $5326193.12   | 0.50%             |  |  |  | Yes           |                  3 | On Loan: No      |
| Cellebrite DI Ltd                                                 | Cellebrite DI Ltd                                                 | CUSIP: 000000000<br>LEI: 254900G03462YGP1IO36 | Long             | EC               | CORP              | IL        |    483364 | NS      | $7733824.00   | 0.72%             |  |  |  | No            |                  1 | On Loan: No      |
| Baldwin Insurance Group Inc/Th                                    | Baldwin Insurance Group Inc/The                                   | CUSIP: 05589G102<br>LEI: N/A                  | Long             | EC               | CORP              | US        |    219206 | NS      | $9384208.86   | 0.87%             |  |  |  | No            |                  1 | On Loan: —       |
| Axon Enterprise Inc                                               | Axon Enterprise Inc                                               | CUSIP: 05464C101<br>LEI: 549300QP2IEEGFE16681 | Long             | EC               | CORP              | US        |     32147 | NS      | $26615787.18  | 2.47%             |  |  |  | No            |                  1 | On Loan: No      |
| Rambus Inc                                                        | Rambus Inc                                                        | CUSIP: 750917106<br>LEI: 2549000211GDCQSLV833 | Long             | EC               | CORP              | US        |    384310 | NS      | $24603526.20  | 2.29%             |  |  |  | No            |                  1 | On Loan: No      |
| QXO Inc                                                           | QXO Inc                                                           | CUSIP: 82846H405<br>LEI: N/A                  | Long             | EC               | CORP              | US        |    772645 | NS      | $16642773.30  | 1.55%             |  |  |  | No            |                  1 | On Loan: —       |
| Confluent Inc                                                     | Confluent Inc                                                     | CUSIP: 20717M103<br>LEI: 254900MRZ83YWUV7SN74 | Long             | EC               | CORP              | US        |    594820 | NS      | $14828862.60  | 1.38%             |  |  |  | No            |                  1 | On Loan: No      |
| Warby Parker Inc                                                  | Warby Parker Inc                                                  | CUSIP: 93403J106<br>LEI: N/A                  | Long             | EC               | CORP              | US        |   1167835 | NS      | $25610621.55  | 2.38%             |  |  |  | No            |                  1 | On Loan: No      |
| Natera Inc                                                        | Natera Inc                                                        | CUSIP: 632307104<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     88470 | NS      | $14946121.80  | 1.39%             |  |  |  | No            |                  1 | On Loan: No      |
| Planet Fitness Inc                                                | Planet Fitness Inc                                                | CUSIP: 72703H101<br>LEI: 549300LLE5HUPF6H8G33 | Long             | EC               | CORP              | US        |    208094 | NS      | $22692650.70  | 2.11%             |  |  |  | No            |                  1 | On Loan: No      |
| BJ's Wholesale Club Holdings I                                    | BJ's Wholesale Club Holdings Inc                                  | CUSIP: 05550J101<br>LEI: 549300UCIWH1C93V0J03 | Long             | EC               | CORP              | US        |    176365 | NS      | $19017437.95  | 1.77%             |  |  |  | No            |                  1 | On Loan: No      |
| Modine Manufacturing Co                                           | Modine Manufacturing Co                                           | CUSIP: 607828100<br>LEI: Z35SZFYJR8GZZRSIUU09 | Long             | EC               | CORP              | US        |    207154 | NS      | $20404669.00  | 1.90%             |  |  |  | No            |                  1 | On Loan: —       |
| Bentley Systems Inc                                               | Bentley Systems Inc                                               | CUSIP: 08265T208<br>LEI: 549300WVEHPGE0Z56F71 | Long             | EC               | CORP              | US        |    310590 | NS      | $16762542.30  | 1.56%             |  |  |  | No            |                  1 | On Loan: No      |
| CoStar Group Inc                                                  | CoStar Group Inc                                                  | CUSIP: 22160N109<br>LEI: 984500Q1D53D08E2E698 | Long             | EC               | CORP              | US        |    263257 | NS      | $21165862.80  | 1.97%             |  |  |  | No            |                  1 | On Loan: No      |
| Curtiss-Wright Corp                                               | Curtiss-Wright Corp                                               | CUSIP: 231561101<br>LEI: TEL51ETZWP7D0ZM4X325 | Long             | EC               | CORP              | US        |     88894 | NS      | $43429163.70  | 4.04%             |  |  |  | No            |                  1 | On Loan: No      |
| HubSpot Inc                                                       | HubSpot Inc                                                       | CUSIP: 443573100<br>LEI: 529900BLNVEW0MVKJB37 | Long             | EC               | CORP              | US        |     16252 | NS      | $9046350.76   | 0.84%             |  |  |  | No            |                  1 | On Loan: No      |
| MYR Group Inc                                                     | MYR Group Inc                                                     | CUSIP: 55405W104<br>LEI: 529900G1IMMZHOQ17I54 | Long             | EC               | CORP              | US        |    118337 | NS      | $21472248.65  | 2.00%             |  |  |  | No            |                  1 | On Loan: No      |
| Dutch Bros Inc                                                    | Dutch Bros Inc                                                    | CUSIP: 26701L100<br>LEI: N/A                  | Long             | EC               | CORP              | US        |    216992 | NS      | $14835743.04  | 1.38%             |  |  |  | No            |                  1 | On Loan: No      |
| Timken Co/The                                                     | Timken Co/The                                                     | CUSIP: 887389104<br>LEI: B0I35MLPFXZSE70ASS73 | Long             | EC               | CORP              | US        |    290214 | NS      | $21055025.70  | 1.96%             |  |  |  | No            |                  1 | On Loan: No      |
| Illumina Inc                                                      | Illumina Inc                                                      | CUSIP: 452327109<br>LEI: SQ95QG8SR5Q56LSNF682 | Long             | EC               | CORP              | US        |    227805 | NS      | $21734875.05  | 2.02%             |  |  |  | No            |                  1 | On Loan: No      |
| Woodward Inc                                                      | Woodward Inc                                                      | CUSIP: 980745103<br>LEI: YPYKXXTR8TFDH54ZMB45 | Long             | EC               | CORP              | US        |     87223 | NS      | $21377485.07  | 1.99%             |  |  |  | No            |                  1 | On Loan: No      |
| Assurant Inc                                                      | Assurant Inc                                                      | CUSIP: 04621X108<br>LEI: H3F39CAXWQRVWURFXL38 | Long             | EC               | CORP              | US        |     96461 | NS      | $19050082.89  | 1.77%             |  |  |  | No            |                  1 | On Loan: No      |
| Xenon Pharmaceuticals Inc                                         | Xenon Pharmaceuticals Inc                                         | CUSIP: 98420N105<br>LEI: 549300XV44Q9Z1MIPQ03 | Long             | EC               | CORP              | CA        |    130668 | NS      | $4089908.40   | 0.38%             |  |  |  | No            |                  1 | On Loan: —       |
| FormFactor Inc                                                    | FormFactor Inc                                                    | CUSIP: 346375108<br>LEI: 549300YCEEO6SZD1ZR61 | Long             | EC               | CORP              | US        |    788647 | NS      | $27137343.27  | 2.52%             |  |  |  | No            |                  1 | On Loan: No      |
| Construction Partners Inc                                         | Construction Partners Inc                                         | CUSIP: 21044C107<br>LEI: 549300MHLFL4E8JLZU44 | Long             | EC               | CORP              | US        |    159684 | NS      | $16971215.52  | 1.58%             |  |  |  | No            |                  1 | On Loan: No      |
| LOCUS ROBOTICS                                                    | LOCUS ROBOTICS                                                    | CUSIP: 000000000<br>LEI: N/A                  | Long             | EC               | CORP              | US        |    101086 | NS      | $4557967.74   | 0.42%             |  |  |  | Yes           |                  3 | On Loan: No      |
| Twist Bioscience Corp                                             | Twist Bioscience Corp                                             | CUSIP: 90184D100<br>LEI: 549300T23BL59LCOH584 | Long             | EC               | CORP              | US        |    174828 | NS      | $6431922.12   | 0.60%             |  |  |  | No            |                  1 | On Loan: No      |
| Repligen Corp                                                     | Repligen Corp                                                     | CUSIP: 759916109<br>LEI: 54930006QJ0T5AUO1E71 | Long             | EC               | CORP              | US        |    191218 | NS      | $23783694.84  | 2.21%             |  |  |  | No            |                  1 | On Loan: No      |
| Privia Health Group Inc                                           | Privia Health Group Inc                                           | CUSIP: 74276R102<br>LEI: N/A                  | Long             | EC               | CORP              | US        |    514921 | NS      | $11843183.00  | 1.10%             |  |  |  | No            |                  1 | On Loan: No      |
| Guardant Health Inc                                               | Guardant Health Inc                                               | CUSIP: 40131M109<br>LEI: 254900M8C3E5VC8BR186 | Long             | EC               | CORP              | US        |    245623 | NS      | $12782220.92  | 1.19%             |  |  |  | No            |                  1 | On Loan: No      |
| ROOFSTOCK                                                         | ROOFSTOCK                                                         | CUSIP: 000000000<br>LEI: N/A                  | Long             | EC               | CORP              | US        |    346123 | NS      | $2055970.62   | 0.19%             |  |  |  | Yes           |                  3 | On Loan: No      |
| Ascendis Pharma A/S                                               | Ascendis Pharma A/S                                               | CUSIP: 04351P101<br>LEI: 549300B66JN3W3J8GH73 | Long             | EC               | CORP              | DK        |     60153 | NS      | $10382407.80  | 0.97%             |  |  |  | No            |                  1 | On Loan: No      |
| SouthState Corp                                                   | SouthState Corp                                                   | CUSIP: 840441109<br>LEI: 549300JZUANXM0YQ4W53 | Long             | EC               | CORP              | US        |    211960 | NS      | $19506678.80  | 1.81%             |  |  |  | No            |                  1 | On Loan: No      |
| Knight-Swift Transportation Ho                                    | Knight-Swift Transportation Holdings Inc                          | CUSIP: 499049104<br>LEI: N/A                  | Long             | EC               | CORP              | US        |    481601 | NS      | $21301212.23  | 1.98%             |  |  |  | No            |                  1 | On Loan: No      |
| Vertiv Holdings Co                                                | Vertiv Holdings Co                                                | CUSIP: 92537N108<br>LEI: 549300KTTIRAOGXCRV69 | Long             | EC               | CORP              | US        |    162271 | NS      | $20837219.11  | 1.94%             |  |  |  | No            |                  1 | On Loan: No      |
| Bio-Techne Corp                                                   | Bio-Techne Corp                                                   | CUSIP: 09073M104<br>LEI: 54930073RLKQ51TILZ35 | Long             | EC               | CORP              | US        |    396667 | NS      | $20408517.15  | 1.90%             |  |  |  | No            |                  1 | On Loan: No      |
| Klaviyo Inc                                                       | Klaviyo Inc                                                       | CUSIP: 49845K101<br>LEI: N/A                  | Long             | EC               | CORP              | US        |    338372 | NS      | $11362531.76  | 1.06%             |  |  |  | No            |                  1 | On Loan: No      |
| Monday.com Ltd                                                    | Monday.com Ltd                                                    | CUSIP: 000000000<br>LEI: 984500MDAFVD86E3B328 | Long             | EC               | CORP              | IL        |     66263 | NS      | $20838388.24  | 1.94%             |  |  |  | No            |                  1 | On Loan: No      |
| DREYFUS INSTITUTIONAL PREFERRE                                    | DREYFUS INSTITUTIONAL PREFERRED GOVERNMENT PLUS MONEY MARKET FUND | CUSIP: 000000000<br>LEI: 549300RBWL04JG8SIX57 | Long             | STIV             | RF                | US        |    563010 | NS      | $563009.56    | 0.05%             |  |  |  | No            |                  1 | On Loan: No      |
| CyberArk Software Ltd                                             | CyberArk Software Ltd                                             | CUSIP: 000000000<br>LEI: 529900YEXNDM894PWS93 | Long             | EC               | CORP              | IL        |     39898 | NS      | $16233698.24  | 1.51%             |  |  |  | No            |                  1 | On Loan: No      |
| Ultragenyx Pharmaceutical Inc                                     | Ultragenyx Pharmaceutical Inc                                     | CUSIP: 90400D108<br>LEI: 529900EV44GVDN1DCX77 | Long             | EC               | CORP              | US        |    107113 | NS      | $3894628.68   | 0.36%             |  |  |  | No            |                  1 | On Loan: No      |
| SiteOne Landscape Supply Inc                                      | SiteOne Landscape Supply Inc                                      | CUSIP: 82982L103<br>LEI: 5299008LX7SBD4HIAU03 | Long             | EC               | CORP              | US        |    114932 | NS      | $13899876.08  | 1.29%             |  |  |  | No            |                  1 | On Loan: No      |
| Ollie's Bargain Outlet Holding                                    | Ollie's Bargain Outlet Holdings Inc                               | CUSIP: 681116109<br>LEI: 529900YO5DSQCPEFDZ05 | Long             | EC               | CORP              | US        |    179078 | NS      | $23598898.84  | 2.19%             |  |  |  | No            |                  1 | On Loan: No      |
| Casella Waste Systems Inc                                         | Casella Waste Systems Inc                                         | CUSIP: 147448104<br>LEI: 8EU0XUFVJ48U37IIDH51 | Long             | EC               | CORP              | US        |    126302 | NS      | $14572724.76  | 1.35%             |  |  |  | No            |                  1 | On Loan: No      |
| ABIOMED Inc                                                       | ABIOMED Inc                                                       | CUSIP: 003CVR016<br>LEI: N/A                  | Long             | EC               | CORP              | US        |    160644 | NS      | $186347.04    | 0.02%             |  |  |  | Yes           |                  3 | On Loan: No      |
| Apogee Therapeutics Inc                                           | Apogee Therapeutics Inc                                           | CUSIP: 03770N101<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     53551 | NS      | $2325719.93   | 0.22%             |  |  |  | No            |                  1 | On Loan: No      |
| Pool Corp                                                         | Pool Corp                                                         | CUSIP: 73278L105<br>LEI: 5493005VZK1KMN6CO617 | Long             | EC               | CORP              | US        |     53326 | NS      | $15543462.48  | 1.44%             |  |  |  | No            |                  1 | On Loan: —       |
| Builders FirstSource Inc                                          | Builders FirstSource Inc                                          | CUSIP: 12008R107<br>LEI: 549300W0SKP6L3H7DP63 | Long             | EC               | CORP              | US        |     90616 | NS      | $10573981.04  | 0.98%             |  |  |  | No            |                  1 | On Loan: No      |
| Newamsterdam Pharma Co NV                                         | Newamsterdam Pharma Co NV                                         | CUSIP: 000000000<br>LEI: 984500B6549TF6E14D36 | Long             | EC               | CORP              | NL        |    187560 | NS      | $3396711.60   | 0.32%             |  |  |  | No            |                  1 | On Loan: —       |
| AeroVironment Inc                                                 | AeroVironment Inc                                                 | CUSIP: 008073108<br>LEI: 529900PGHVI29YLZ6221 | Long             | EC               | CORP              | US        |     90281 | NS      | $25725570.95  | 2.39%             |  |  |  | No            |                  1 | On Loan: —       |

### Signature

**Date Signed:** 2025-08-25

**Name of Applicant:** BNY Mellon Investment Funds I

**Signature:** James Windels

**Name of Signer:** James Windels

**Title:** Treasurer